The company was founded in 2016 by a team of five partners with backgrounds in real estate, healthcare, construction, finance, and film and television. They currently manage 5 billion yuan and invest mainly in healthcare, big health, culture and entertainment, TMT, and fintech. CQY has invested in several pre-IPO projects, including Bona Film, MOE Books, and Lime Film, as well as Flycor Biomedical, a leading allergen detection equipment company. In 2017, they established a 3.17 billion yuan cinema acquisition fund. The company's core concept is to create the most valuable fund for investors by expanding into diversified businesses such as securities investment, mezzanine investment, merger and acquisition fund, and wealth management.